Can you switch from semaglutide to tirzepatide?

Short answer: Yes, switching is possible, but it is a clinical decision and doses are not interchangeable. Semaglutide acts on the GLP-1 receptor; tirzepatide acts on both GIP and GLP-1 receptors, so a provider restarts dose escalation on the new medication rather than matching milligram to milligram. Common reasons to consider a switch include a plateau at a maximum tolerated dose, side effects that do not settle, or supply considerations. Your provider will review your history, set a starting dose, and schedule follow-up to monitor tolerability through the transition. Do not attempt to self-convert doses.

Doses are not equivalent between the two molecules — escalation restarts.
Common triggers: plateau at max tolerated dose, unresolved side effects, supply.
Provider sets the starting dose and follow-up schedule.
Never self-convert or overlap doses on your own.

Begin Eligibility Review See Plans & Pricing

What the transition looks like

Typically the previous medication stops, the new one begins at a starting dose on the normal weekly schedule, and escalation follows tolerability. Expect the familiar cluster of gastrointestinal effects around early increases even if you tolerated your prior medication well.

Frequently asked questions

Will I lose progress during the switch?

Response varies. Providers plan the transition to limit gaps, but appetite effects can shift while the new dose escalates.

Does switching cost more?

Program pricing starts at $249 per 28-day cycle; the applicable plan depends on the pathway and dose. The pricing page lists current plans.

Can I switch back?

That is again a clinical decision made with your provider based on tolerability and response.

Program details

Patient education, not medical advice. Compounded medications are not FDA-approved. RenewMD does not serve Louisiana.